Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Archives of Internal Medicine|April 1, 1979
Pericarditis: differential diagnostic considerationsR C Agner, H A GallisSouthern Medical Journal|December 1, 1989
Waterhouse-Friderichsen syndrome caused by Haemophilus influenzae type b in an immunocompetent young adultW P McKinney, R C AgnerAviation, Space, and Environmental Medicine|March 1, 1992
Decompression sickness: an increasing risk for the private pilotW R Black, R L DeHartJournal of Cardiopulmonary Rehabilitation|March 1, 1996
Strength training early after myocardial infarctionW D Daub, G P Knapik, W R BlackThe Canadian Journal of Cardiology|December 1, 1990
Effect of rate-adapting atrioventricular delay on stroke volume and cardiac output during atrial synchronous pacingM Rees, R G Haennel, W R Black, et al.Journal of the American Geriatrics Society|February 1, 1992
The impact of pacemaker implantation on cognitive functioning in elderly patientsK Rockwood, A R Dobbs, B G Rule, et al.Pacing and Clinical Electrophysiology : PACE|November 1, 1994
Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: effectiveness, needs, and resources. North American Society of Pacing and ElectrophysiologyA D Bernstein, M E Irwin, V Parsonnet, et al.Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Single agent vincristine by infusion in refractory multiple myelomaD V Jackson, L D Case, E K Pope, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology AssociationH B Muss, H B Wells, E H Paschold, et al.Pageof 2